The Mayo MGRS Prediction Tool calculates the risk of finding monoclonal gammopathy of renal significance in a kidney biopsy in patients with monoclonal gammopathy
- Journal:
- Kidney International
- Published:
- DOI:
- 10.1016/j.kint.2025.04.018
- Affiliations:
- 6
- Authors:
- 7
| Institutions | Authors | Share |
|---|---|---|
| Mayo Clinic, United States of America (USA) | 0.64 | |
| University of Minnesota (UMN), United States of America (USA) | 0.36 |